Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Return on Equity: 2011-2025

Historic Return on Equity for Anika Therapeutics (ANIK) over the last 13 years, with Sep 2025 value amounting to -0.13%.

  • Anika Therapeutics' Return on Equity fell 7.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of -0.26% for FY2024, which is 6.00% up from last year.
  • According to the latest figures from Q3 2025, Anika Therapeutics' Return on Equity is -0.13%, which was up 60.43% from -0.32% recorded in Q2 2025.
  • Anika Therapeutics' Return on Equity's 5-year high stood at 0.05% during Q2 2024, with a 5-year trough of -0.32% in Q2 2025.
  • Its 3-year average for Return on Equity is -0.10%, with a median of -0.03% in 2023.
  • As far as peak fluctuations go, Anika Therapeutics' Return on Equity climbed by 11bps in 2021, and later crashed by 37bps in 2025.
  • Over the past 5 years, Anika Therapeutics' Return on Equity (Quarterly) stood at 0.02% in 2021, then dropped by 2bps to 0.00% in 2022, then fell by 1bps to -0.01% in 2023, then dropped by 27bps to -0.28% in 2024, then declined by 7bps to -0.13% in 2025.
  • Its last three reported values are -0.13% in Q3 2025, -0.32% for Q2 2025, and -0.30% during Q1 2025.